ALB and chronic kidney disease: Berg et al. demonstrated that the concentration of carbamylated albumin was approximately 2-fold higher in patients with both CKD (stages 3 and 4) and ESRD than in nonuremic patients, and that the positive correlation between BUN and carbamylated albumin was stronger in patients with CKD who were not on dialysis than in those with ESRD.